A. Yam

发表

Anticorps anti-pd-1, compositions comprenant des anticorps anti-pd-1 et procédés d'utilisation d'anticorps anti-pd-1

A. Gill, A. Yam, R. Stafford, 2015 .

Engineering toward a bacterial “endoplasmic reticulum” for the rapid expression of immunoglobulin proteins

E. Green, Junhao Yang, Alexander R. Steiner, 2014, mAbs.

Conjugués d'anticorps anti-cd74, compositions comprenant des conjugués d'anticorps anti-cd74 et méthodes d'utilisations desdits conjugués d'anticorps anti-cd74

A. Gill, Xiaofan Li, A. Sato, 2017 .

Production of site-specific antibody-drug conjugates using optimized non-natural amino acids in a cell-free expression system.

C. J. Murray, Avinash Gill, E. Zimmerman, 2014, Bioconjugate chemistry.

ARID5B as a critical downstream target of the TAL1 complex that activates the oncogenic transcriptional program and promotes T-cell leukemogenesis

Z. Gong, D. Tenen, P. C. T. Ngoc, 2017, Genes & development.

A New Insect-Specific Flavivirus from Northern Australia Suppresses Replication of West Nile Virus and Murray Valley Encephalitis Virus in Co-infected Mosquito Cells

J. Hobson-Peters, S. Davis, R. Weir, 2013, PloS one.

Enhancer profiling identifies critical cancer genes and characterizes cell identity in adult T-cell leukemia.

N. Gray, Tinghu Zhang, S. Iida, 2017, Blood.

Viral RNA Intermediates as Targets for Detection and Discovery of Novel and Emerging Mosquito-Borne Viruses

M. Ng, J. Hobson-Peters, N. Prow, 2015, PLoS neglected tropical diseases.

RF1 attenuation enables efficient non-natural amino acid incorporation for production of homogeneous antibody drug conjugates

C. J. Murray, R. Stafford, A. Gill, 2017, Scientific Reports.

Targeting CD74 in B-cell non-Hodgkin lymphoma with the antibody-drug conjugate STRO-001

M. Embry, R. Stafford, R. Henningsen, 2023, Oncotarget.

RF1 attenuation enables efficient non-natural amino acid incorporation for production of homogeneous antibody drug conjugates

C. J. Murray, R. Stafford, A. Gill, 2017, Scientific Reports.

Targeting CD74 in multiple myeloma with the novel, site-specific antibody-drug conjugate STRO-001

M. Embry, R. Stafford, Xiaofan Li, 2018, Oncotarget.

Abstract 1782: Discovery and activity of STRO-002, a novel ADC targeting folate receptor alpha for ovarian and endometrial cancer

Joy J. Chen, R. Stafford, R. Henningsen, 2018, Immunology.

Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19

J. Dye, S. Pokhrel, R. Begley, 2022, Frontiers in Immunology.

Discovery of STRO-002, a Novel Homogeneous ADC Targeting Folate Receptor Alpha, for the Treatment of Ovarian and Endometrial Cancers

R. Stafford, R. Henningsen, Cuong Tran, 2022, Molecular cancer therapeutics.